rozanolixizumab

Italy

Drugs containing this active substance

  • RYSTIGGO

    It is used in adults for the treatment of generalized Myasthenia Gravis (gMG), an autoimmune disease that causes muscle weakness, extreme fatigue, shortness of breath, and difficulty swallowing.

    Form: solution for injection

    Active substance Dosage
    rozanolixizumab -

    ATC: L04AG16

    Manufacturer: UCB PHARMA S.A.